BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3109744)

  • 1. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma.
    Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA
    Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
    J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
    Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
    J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
    J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
    Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
    J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identity between murine gamma interferon and macrophage activating factor.
    Schultz RM; Kleinschmidt WJ
    Nature; 1983 Sep 15-21; 305(5931):239-40. PubMed ID: 6412144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against mouse gamma-interferon inhibit tumoricidal macrophage activation by T lymphocytes.
    Landolfo S; Cofano F; Gandino L; Gribaudo G; Prat M
    Exp Cell Biol; 1985; 53(5):265-9. PubMed ID: 3930308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.
    Nakajima H; Izumi Y; Sugihara S; Satoh Y; Isumi S; Gotoh T; Fujiwara H; Hamaoka T
    Cancer Immunol Immunother; 1987; 25(3):201-8. PubMed ID: 3119213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma).
    Fukazawa Y; Kagaya K; Miura H; Shinoda T; Natori K; Yamazaki S
    Microbiol Immunol; 1984; 28(6):691-702. PubMed ID: 6434908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
    Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
    J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
    Kleinschmidt WJ; Schultz RM
    J Interferon Res; 1982; 2(2):291-9. PubMed ID: 6811671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    Nathan CF; Murray HW; Wiebe ME; Rubin BY
    J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of immune interferon (IFN-gamma) in lymphokine-induced anti-toxoplasma activity: studies with recombinant murine IFN-gamma.
    Sethi KK; Omata Y; Brandis H
    Immunobiology; 1985 Nov; 170(4):270-83. PubMed ID: 3936779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
    Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
    Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.